Gaeta Renee 4
4 · Candel Therapeutics, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Gaeta Renee
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+14,240→ 14,240 totalExercise: $4.94Exp: 2035-06-17→ Common Stock (14,240 underlying)
Footnotes (1)
- [F1]This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.